Advanced search
Publication Cover
COPD: Journal of Chronic Obstructive Pulmonary Disease Volume 9, 2012 - Issue 3
Submit an article Journal homepage
394
Views
2
CrossRef citations to date
0
Altmetric
EDITORIAL

Sildenafil for COPD: A Randomized Crossover Trial

Todd BullTodd Bull, MD, Associate Professor of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Aurora, CO. Email: [email protected], Ph: 303-724-6055.
&
David B. BadeschDavid B. Badesch, MD, Professor of Medicine, Divisions of Pulmonary Sciences and Critical Care Medicine, and Cardiology, University of Colorado Denver, Leprino Building, Rm 536 or Box 957, 12401 E. 17th Ave., Aurora, CO 80045. Email: [email protected], Cell: 303-880-8808.Correspondence[email protected]
Pages 211-212 | Published online: 15 May 2012

References

  • Kessler, R., M. Faller, E. Weitzenblum, A. Chaouat, A. Aykut, A. Ducolone, M. Ehrhart, and M. Oswald-Mammosser. 2001. “Natural history” of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am. J Respir. Crit Care Med. 164:219–224.
  • Kessler, R., M. Faller, G. Fourgaut, B. Mennecier, and E. Weitzenblum. 1999. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am. J Respir. Crit Care Med. 159:158–164.
  • Traver, G. A., M. G. Cline, and B. Burrows. 1979. Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study. Am. Rev. Respir. Dis. 119:895–902.
  • Weitzenblum, E., C. Hirth, A. Ducolone, R. Mirhom, J. Rasaholinjanahary, and M. Ehrhart. 1981. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 36:752–758.
  • Thabut, G., G. Dauriat, J. B. Stern, D. Logeart, A. Levy, R. Marrash-Chahla, and H. Mal. 2005. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 127:1531–1536.
  • Cuttica, M. J., R. Kalhan, O. A. Shlobin, S. Ahmad, M. Gladwin, R. F. Machado, S. D. Barnett, and S. D. Nathan. 2010. Categorization and impact of pulmonary hypertension in patients with advanced COPD. Respir. Med.
  • Scharf, S. M., M. Iqbal, C. Keller, G. Criner, S. Lee, and H. E. Fessler. 2002. Hemodynamic characterization of patients with severe emphysema. Am. J Respir. Crit Care Med. 166:314–322.
  • Oswald-Mammosser, M., E. Weitzenblum, E. Quoix, G. Moser, A. Chaouat, C. Charpentier, and R. Kessler. 1995. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest 107:1193–1198.
  • Chaouat, A., A. S. Bugnet, N. Kadaoui, R. Schott, I. Enache, A. Ducolone, M. Ehrhart, R. Kessler, and E. Weitzenblum. 2005. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am. J Respir. Crit Care Med. 172:189–194.
  • McLaughlin, V. V., S. L. Archer, D. B. Badesch, R. J. Barst, H. W. Farber, J. R. Lindner, M. A. Mathier, M. D. McGoon, M. H. Park, R. S. Rosenson, 2009. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am. Coll. Cardiol. 53:1573–1619.
  • Badesch, D. B., S. H. Abman, G. Simonneau, L. J. Rubin, and V. V. McLaughlin. 2007. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest 131:1917–1928.
  • Humbert, M. and V. V. McLaughlin. 2009. The 4th World Symposium on Pulmonary Hypertension. Introduction. J Am. Coll. Cardiol. 54:S1–S2.
  • Galie, N., H. A. Ghofrani, A. Torbicki, R. J. Barst, L. J. Rubin, D. Badesch, T. Fleming, T. Parpia, G. Burgess, A. Branzi, 2005. Sildenafil citrate therapy for pulmonary arterial hypertension. N. Engl. J Med. 353:2148–2157.
  • Blanco, I., E. Gimeno, P. A. Munoz, S. Pizarro, C. Gistau, R. Rodriguez-Roisin, J. Roca, and J. A. Barbera. 2010. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am. J Respir. Crit Care Med. 181: 70–278.
  • Stolz, D., H. Rasch, A. Linka, M. Di Valentino, A. Meyer, M. Brutsche, and M. Tamm. 2008. A randomised, controlled trial of bosentan in severe COPD. Eur. Respir. J 32:619–628.
  • Collard, H. R., K. J. Anstrom, M. I. Schwarz, and D. A. Zisman. 2007. Sildenafil improves walk distance in idiopathic pulmonary fibrosis. Chest 131:897–899.
  • Zisman, D. A., M. Schwarz, K. J. Anstrom, H. R. Collard, K. R. Flaherty, and G. W. Hunninghake. 2010. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N. Engl. J. Med. 363:620–628.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.